License allows AlgenScribe to expand its research and development activities using CRISPR/Cas9. DUBLIN and NICE, France, Sept. 5, 2023 /PRNewswire/ — ERS Genomics Limited (‘ERS’) is pleased to announce a new license agreement with AlgenScribe SAS (‘AlgenScribe’). This is a non-exclusive…